FDA Approved: PROGRAF — Supplemental Application (Astellas Pharma US, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for PROGRAF (tacrolimus) from Astellas Pharma US, Inc., updating its label to cover transplant-related indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplantation
• Kidney Transplantation
• Liver Transplantation
• Pancreas Transplantation

Drugs mentioned

• Prograf (Tacrolimus)

Snippet

SUPPL AP for PROGRAF (TACROLIMUS)